Skip to content
OpenCapital
Get started

USANA Health Sciences USNA Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest

Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest at other companies

Herbalife logo
HerbalifeHLF
——

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$363.35M-36.1%
P/E18.1×+7.8×
P/S0.4×-0.3×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Return on equity3.2%-7.6pp
Debt / equity0×0.0×
Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USANA Health Sciences's comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest?
USANA Health Sciences (USNA) reported comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest of $8.7M in Q1 2026.
How has USANA Health Sciences's comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest changed year-over-year?
USANA Health Sciences's comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest decreased by 5.5% year-over-year, from $9.21M to $8.7M.
What is the long-term trend for USANA Health Sciences's comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest?
Over 2 years (2022 to 2025), USANA Health Sciences's comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest has grown at a -43.4% compound annual growth rate (CAGR), from $56.11M to $17.97M.
What does comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest mean?
Represents the total comprehensive income for the period, encompassing both net income and other comprehensive income items, inclusive of amounts attributable to noncontrolling interests. This metric offers a comprehensive view of the total economic value generated by the entire corporate entity.